{{medical}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 400144128
| IUPAC_name = ''L''-histidyl-''L''-alanyl-''L''-α-glutamylglycyl-''L''-threonyl-''L''-phenylalanyl-''L''-threonyl-''L''-seryl-''L''-α-aspartyl-''L''-valyl-''L''-seryl-''L''-seryl-''L''-tyrosyl-''L''-leucyl-''L''-α-glutamylglycyl-''L''-glutaminyl-''L''-alanyl-''L''-alanyl-N<sup>6</sup>-[N-(1-oxohexadecyl)-''L''-γ-glutamyl]-''L''-lysyl-''L''-α-glutamyl-''L''-phenylalanyl-''L''-isoleucyl-''L''-alanyl-''L''-tryptophyl-''L''-leucyl-''L''-valyl-''L''-arginylglycyl-''L''-arginyl-glycine
| synonyms = Arg<sup>34</sup>Lys<sup>26</sup>-(''N''-ε-(γ-Glu(''N''-α-hexadecanoyl)))-GLP-1[7-37] 
| image = Liraglutide structure.svg
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 24571200
| InChI = 1/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-128(223)193-112(59-64-132(227)228)148(244)180-68-41-40-50-111(154(250)199-116(62-67-135(233)234)155(251)204-120(73-100-44-33-31-34-45-100)160(256)214-140(93(11)19-2)168(264)192-97(15)146(242)201-122(76-103-79-183-108-49-39-38-48-106(103)108)158(254)203-118(72-90(5)6)159(255)212-138(91(7)8)166(262)200-110(52-43-70-182-172(177)178)150(246)184-81-129(224)194-109(51-42-69-181-171(175)176)149(245)187-84-137(237)238)196-144(240)95(13)189-143(239)94(12)191-153(249)115(58-63-127(174)222)195-130(225)82-185-152(248)114(61-66-134(231)232)198-156(252)117(71-89(3)4)202-157(253)119(75-102-54-56-105(221)57-55-102)205-163(259)124(85-216)208-165(261)126(87-218)209-167(263)139(92(9)10)213-162(258)123(78-136(235)236)206-164(260)125(86-217)210-170(266)142(99(17)220)215-161(257)121(74-101-46-35-32-36-47-101)207-169(265)141(98(16)219)211-131(226)83-186-151(247)113(60-65-133(229)230)197-145(241)96(14)190-147(243)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,244)(H,184,246)(H,185,248)(H,186,247)(H,187,245)(H,189,239)(H,190,243)(H,191,249)(H,192,264)(H,193,223)(H,194,224)(H,195,225)(H,196,240)(H,197,241)(H,198,252)(H,199,250)(H,200,262)(H,201,242)(H,202,253)(H,203,254)(H,204,251)(H,205,259)(H,206,260)(H,207,265)(H,208,261)(H,209,263)(H,210,266)(H,211,226)(H,212,255)(H,213,258)(H,214,256)(H,215,257)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1
| InChIKey = KAIWQAZASNVPLR-QCIJIYAXBI
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-128(223)193-112(59-64-132(227)228)148(244)180-68-41-40-50-111(154(250)199-116(62-67-135(233)234)155(251)204-120(73-100-44-33-31-34-45-100)160(256)214-140(93(11)19-2)168(264)192-97(15)146(242)201-122(76-103-79-183-108-49-39-38-48-106(103)108)158(254)203-118(72-90(5)6)159(255)212-138(91(7)8)166(262)200-110(52-43-70-182-172(177)178)150(246)184-81-129(224)194-109(51-42-69-181-171(175)176)149(245)187-84-137(237)238)196-144(240)95(13)189-143(239)94(12)191-153(249)115(58-63-127(174)222)195-130(225)82-185-152(248)114(61-66-134(231)232)198-156(252)117(71-89(3)4)202-157(253)119(75-102-54-56-105(221)57-55-102)205-163(259)124(85-216)208-165(261)126(87-218)209-167(263)139(92(9)10)213-162(258)123(78-136(235)236)206-164(260)125(86-217)210-170(266)142(99(17)220)215-161(257)121(74-101-46-35-32-36-47-101)207-169(265)141(98(16)219)211-131(226)83-186-151(247)113(60-65-133(229)230)197-145(241)96(14)190-147(243)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,244)(H,184,246)(H,185,248)(H,186,247)(H,187,245)(H,189,239)(H,190,243)(H,191,249)(H,192,264)(H,193,223)(H,194,224)(H,195,225)(H,196,240)(H,197,241)(H,198,252)(H,199,250)(H,200,262)(H,201,242)(H,202,253)(H,203,254)(H,204,251)(H,205,259)(H,206,260)(H,207,265)(H,208,261)(H,209,263)(H,210,266)(H,211,226)(H,212,255)(H,213,258)(H,214,256)(H,215,257)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KAIWQAZASNVPLR-QCIJIYAXSA-N
| CAS_number = 204656-20-2
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_supplemental = 
| ATC_prefix = A10
| ATC_suffix = BX07
| ATC_supplemental = 
| PubChem = 
| DrugBank = 
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D06404
| chemical_formula = 
| C=172 | H=265 | N=43 | O=51
| molecular_weight = 3751.20 g/mol
| smiles = CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2c[nH]c3c2cccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccc(cc4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc6cnc[nH]6)N
| bioavailability = N/A
| protein_bound = 
| metabolism = 
| elimination_half-life = 11-15 hours
| excretion = 
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category=
| legal_AU =
| legal_CA =
| legal_UK =  POM
| legal_US =  Rx-only
| legal_status = 
| routes_of_administration = Subcutaneous
| licence_EU = Victoza
| licence_US = Liraglutide
}}
'''利拉鲁肽'''（英语：Liraglutide），商品名为'''诺和力'''（Victoza）。是一种人[[胰高血糖素样肽-1类似物|胰高血糖素样肽-1类似物]]（GLP-1类似物），用于治疗[[糖尿病|糖尿病]]。<ref>{{Cite web |url=http://www.drugs.com/nda/liraglutide_080530.html |title=May 2008 |accessdate=2011-04-22 |archive-date=2020-05-02 |archive-url=https://web.archive.org/web/20200502162410/https://www.drugs.com/nda/liraglutide_080530.html |dead-url=no }}</ref><ref>{{Cite web |url=http://www.medicalnewstoday.com/articles/110349.php |title="Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, And Blood Pressure In Patients With Type 2 Diabetes" June 2008 |accessdate=2011-04-22 |archive-date=2009-02-05 |archive-url=https://web.archive.org/web/20090205233559/http://www.medicalnewstoday.com/articles/110349.php |dead-url=no }}</ref><ref>{{Cite web |url=http://www.novonordisk.com/science/about_rd/quarterly_rd_update.asp |title=Oct 2008 Inc results of LEAD 6 extension |accessdate=2011-04-22 |archive-date=2010-01-09 |archive-url=https://web.archive.org/web/20100109101501/http://www.novonordisk.com/science/about_rd/quarterly_rd_update.asp |dead-url=no }}</ref>

==药剂学==
该药物的活性成分是利用[[基因工程|基因工程]]技术使用[[酵母|酵母]]生产的GLP-1（胰高血糖素样肽-1）类似物。药物制剂种还含有二水合磷酸氢二钠、丙二醇、盐酸和/或氢氧化钠（仅作为pH调节剂）、苯酚和注射用水等成分。药剂成品为无色或几乎无色的澄明等渗液；pH=8. 15。

==临床应用==
利拉鲁肽主要用于成人2型糖尿病患者控制血糖：适用于单用二甲双胍或磺脲类药物最大可耐受剂量治疗后血糖仍控制不佳的患者，与二甲双胍或磺脲类药物联合应用。
<ref>糖尿病{{cite web |url=http://lllt.tnbzy.com/ |title=存档副本 |accessdate=2012-09-17 |deadurl=yes |archiveurl=https://web.archive.org/web/20121024102011/http://lllt.tnbzy.com/ |archivedate=2012-10-24 }}</ref>

==储存==
利拉鲁肽制剂应冷藏于2℃-8℃冰箱中，不可冷冻。

==参考资料==
{{reflist}}

{{口服降糖药和胰岛素类似物}}
{{Peptidergics}}

[[Category:糖尿病药物|Category:糖尿病药物]]